Twist Bioscience Corp SEC filings TWST

Twist Bioscience Corp has 1,001 filings in SEC EDGAR's recent list, going back to Oct 4, 2022. Its latest annual report, Form ARS, was filed on Jan 6, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 3, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 19, 2026 (other events). The company's fiscal year ends on September 30.

Form Description Filed Period
8-K Current report
Other events
 Aug 19, 2026 Aug 19, 2026
8-K Current report
Regulation FD disclosure
 Aug 19, 2026 Aug 18, 2026
8-K Current report
Material agreement, Regulation FD disclosure
 Aug 5, 2026 Aug 4, 2026
8-K Current report
Results of operations
 Aug 3, 2026 Aug 3, 2026
8-K Current report
Results of operations
 May 4, 2026 May 4, 2026
8-K Current report
Unregistered share sale, Other events
 Feb 17, 2026 Feb 11, 2026
8-K Current report
Shareholder vote results
 Feb 6, 2026 Feb 5, 2026
8-K Current report
Results of operations
 Feb 2, 2026 Feb 2, 2026
8-K Current report
Results of operations
 Jan 12, 2026 Jan 12, 2026
8-K Current report
Results of operations
 Nov 14, 2025 Nov 14, 2025
8-K Current report
Officer or director change
 Aug 6, 2025 Aug 5, 2025
8-K Current report
Results of operations
 Aug 4, 2025 Aug 4, 2025
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
 May 5, 2025 May 2, 2025
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
 Feb 11, 2025 Feb 5, 2025
8-K Current report
Results of operations
 Feb 3, 2025 Feb 3, 2025
8-K Current report
Results of operations
 Nov 18, 2024 Nov 18, 2024
8-K Current report
Officer or director change
 Oct 15, 2024 Oct 8, 2024
8-K Current report
Results of operations
 Aug 2, 2024 Aug 2, 2024
8-K Current report
Results of operations
 May 2, 2024 May 2, 2024
8-K Current report
Shareholder vote results
 Feb 7, 2024 Feb 6, 2024
8-K Current report
Results of operations
 Feb 2, 2024 Feb 2, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
 Jan 5, 2024 Jan 5, 2024
8-K Current report
Results of operations
 Nov 17, 2023 Nov 17, 2023
8-K Current report
Results of operations, Officer or director change
 Aug 4, 2023 Aug 3, 2023
8-K/A Amended current report
Exit or restructuring costs
 Aug 4, 2023 May 3, 2023
8-K Current report
Officer or director change
 May 23, 2023 May 23, 2023
8-K Current report
Results of operations, Exit or restructuring costs
 May 5, 2023 May 3, 2023
8-K Current report
Officer or director change
 Mar 28, 2023 Mar 23, 2023
8-K Current report
Shareholder vote results
 Feb 8, 2023 Feb 7, 2023
8-K Current report
Results of operations
 Feb 3, 2023 Feb 3, 2023
8-K Current report
Bylaw or fiscal year change
 Nov 18, 2022 Nov 17, 2022
8-K Current report
Results of operations
 Nov 18, 2022 Nov 18, 2022
8-K Current report
Regulation FD disclosure
 Nov 16, 2022 Nov 15, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
 Oct 26, 2022 Oct 25, 2022

Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
TWST (Nasdaq)
Fiscal year ends
September 30
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1581280

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.